Literature DB >> 21653646

Genetically lowered microsomal epoxide hydrolase activity and tobacco-related cancer in 47,000 individuals.

Julie Lee1, Morten Dahl, Børge G Nordestgaard.   

Abstract

BACKGROUND: Two functional polymorphisms of the microsomal epoxide hydrolase (mEH) gene (EPHX1), Tyr113His (rs1051740) and His139Arg (rs2234922), have variably been found to influence susceptibility to various cancer forms. We tested whether genetically lowered mEH activity affects risk of developing cancer in the general population.
METHODS: We genotyped 47,089 individuals from the Danish general population for the Tyr113His and His139Arg polymorphisms in the EPHX1 gene and divided them into groups with predicted fast, intermediate, and slow mEH activity. Using Cox proportional hazards models, we calculated HRs for 26 individual cancer diagnoses and for groups of any cancer, tobacco-related cancers, estrogen-related female cancers, and other cancers.
RESULTS: Of the 47,089 individuals, 7,590 experienced a cancer event, and of these, 1,466 were tobacco-related. After multifactorial adjustment, the HRs (95% CI) for tobacco-related cancer were 1.1 (0.8-1.5) and 1.5 (1.1-2.0) in individuals with intermediate and slow mEH activity versus individuals with the fast phenotype (P(trend) = 0.003). The corresponding HRs among ever-smokers were 1.1 (0.8-1.5) and 1.5 (1.1-2.0; P(trend) = 0.003), whereas HRs among never-smokers did not differ from 1.0.
CONCLUSIONS: Our results indicate that genetically lowered mEH activity is associated with increased risk of developing tobacco-related cancer among smokers in the general population; however, additional studies are needed to confirm our findings. IMPACT: To our knowledge, this is the largest study to investigate the association of mEH phenotype and genotype with tobacco-related cancers combined in the general population. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21653646     DOI: 10.1158/1055-9965.EPI-10-1165

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  5 in total

Review 1.  Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer.

Authors:  Shanbeh Zienolddiny; Vidar Skaug
Journal:  Lung Cancer (Auckl)       Date:  2011-12-29

Review 2.  Microsomal epoxide hydrolase 1 (EPHX1): Gene, structure, function, and role in human disease.

Authors:  Radka Václavíková; David J Hughes; Pavel Souček
Journal:  Gene       Date:  2015-07-26       Impact factor: 3.688

3.  Quantitative assessment of the influence of EPHX1 gene polymorphisms and cancer risk: a meta-analysis with 94,213 subjects.

Authors:  Xiaoqin Yang; Yubing Wang; Guiping Wang
Journal:  J Exp Clin Cancer Res       Date:  2014-09-28

4.  A Predictive Model Assessing Genetic Susceptibility Risk at Workplace.

Authors:  Pieranna Chiarella; Pasquale Capone; Damiano Carbonari; Renata Sisto
Journal:  Int J Environ Res Public Health       Date:  2019-06-05       Impact factor: 3.390

5.  Genetic enhancement of microsomal epoxide hydrolase improves metabolic detoxification but impairs cerebral blood flow regulation.

Authors:  Anne Marowsky; Karen Haenel; Ernesto Bockamp; Rosario Heck; Sibylle Rutishauser; Nandkishor Mule; Diana Kindler; Markus Rudin; Michael Arand
Journal:  Arch Toxicol       Date:  2016-02-02       Impact factor: 5.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.